Literature DB >> 6492942

Tyramine pressor test: implications and limitations.

K Ghose.   

Abstract

Tyramine, an indirectly acting sympathomimetic amine, can be used as a pharmacological tool to assess the peripheral adrenergic activity and its interactions with drugs in man. Of the various techniques used, the tyramine pressor test appears to be the most reliable method. It is convenient to perform and carries no significant morbidity, provided the subjects are selected carefully and the investigation is closely monitored. Basically, the tyramine pressor test involves measurement of systolic blood pressure in response to bolus intravenous tyramine injections. Tyramine sensitivity, which is taken as an index of peripheral adrenergic function, is defined as the amount of tyramine required to increase the systolic blood pressure by 30 mm of Hg and is determined from the dose response curve. Drugs which influence the adrenergic system are likely to alter the tyramine sensitivity. It provides valuable guidance regarding drug interactions and is useful in the assessment of certain neuropsychiatric conditions. However, since tyramine does not cross the blood brain barrier, information regarding only the peripheral effect is obtained.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492942

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  7 in total

1.  An investigation of components of variance and tachyphylaxis in a placebo-controlled intravenous tyramine study.

Authors:  M V Cantarini; C L Watkins; J Growcott; A M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Intravenous amine pressor tests in healthy volunteers. Within- and between subject variances and sex differences.

Authors:  I W Reimann; L Firkusny; K H Antonin; P R Bieck
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Effect of oral linezolid on the pressor response to intravenous tyramine.

Authors:  Mireille V Cantarini; Catherine J Painter; Elaine M Gilmore; Catherine Bolger; Claire L Watkins; Andrew M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.

Authors:  S Flanagan; K Bartizal; S L Minassian; E Fang; P Prokocimer
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

5.  Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man.

Authors:  I W Reimann; L Firkusny; K H Antonin; P R Bieck
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Dietary trace amine-dependent vasoconstriction in porcine coronary artery.

Authors:  A A Herbert; E J Kidd; K J Broadley
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

7.  Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.

Authors:  Fahad Aldosary; Sandhaya Norris; Philippe Tremblay; Jonathan S James; James C Ritchie; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.